Structural and functional insights into Ubl domain-mediated regulation of SARS-CoV-2 PLpro.

Structural and functional insights into Ubl domain-mediated regulation of SARS-CoV-2 PLpro.

Publication date: Oct 03, 2025

SARS-CoV-2 papain-like protease (PLpro) is essential for viral replication and immune evasion. It contains an N-terminal ubiquitin-like (Ubl) domain, whose involvement in enzymatic function remains poorly understood. In this study, we investigated the role of the Ubl domain in modulating the structural dynamics and catalytic efficiency of PLpro. Using molecular dynamics (MD) simulations, inhibitor binding assays, and steady-state kinetic analyses, we found that the Ubl domain stabilizes critical structural elements, notably the ridge helix in the thumb subdomain. Removal of the Ubl domain altered substrate processing, reducing catalytic efficiency of the enzyme. Interestingly, free ubiquitin enhanced enzymatic activity, likely via non-canonical binding sites distinct from the SUb1 and SUb2 sites. These findings uncover a regulatory role for the Ubl domain in allosteric modulation of PLpro activity and reveal additional layers of enzymatic plasticity. Understanding these mechanisms could guide the design of future antiviral therapeutics targeting PLpro’s regulatory or allosteric sites.

Concepts Keywords
Antiviral Binding Sites
Efficiency Coronavirus 3C Proteases
Molecular Coronavirus 3C Proteases
Thumb Coronavirus Papain-Like Proteases
Viral Coronavirus Papain-Like Proteases
COVID-19
Deubiquitination and deISGylation
Humans
ISG15
Kinetics
Molecular Dynamics Simulation
Papain-like protease
papain-like protease, SARS-CoV-2
Protein Domains
SARS-CoV-2
SARS-CoV-2
Ubiquitin
Ubiquitin
Ubiquitin
Ubl domain

Semantics

Type Source Name
pathway KEGG Viral replication
disease IDO role
disease MESH COVID-19
pathway REACTOME Deubiquitination
drug DRUGBANK Papain
disease IDO protein

Original Article

(Visited 10 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *